Executive officer

Eric Shroff

Senior Vice President, Rapid and Molecular Diagnostics·Abbott Laboratories

About

Eric Shroff has served as Senior Vice President, Rapid and Molecular Diagnostics of Abbott since 2025.

He previously served as Vice President, Abbott Point of Care from 2018 to 2025 and was elected a corporate officer in 2018.

Since 2025
Age 54
Tenure 1 yr

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director RM Robert J. Alpern, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director

Roles

Organization Role Dates Details
Abbott Laboratories Senior Vice President, Rapid and Molecular Diagnostics 2025–present Current role
Abbott Laboratories Vice President, Abbott Point of Care 2018 to 2025
Abbott Diabetes Care Divisional Vice President, Asia Pacific Led commercial operations across Australia, New Zealand, Greater China, India, Japan, Korea, and Southeast Asia, before becoming VP, Abbott Point of Care in November 2018. Joined Abbott in 2003.
Booz Allen & Hamilton, Ernst & Young, and Whittman-Hart Management consultant Served financial services and healthcare clients on strategic planning, corporate development and operations improvement before joining Abbott.

Related

Source: Abbott Laboratories SEC filings and official company website

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo